|

Anlotinib, Everolimus and Tislelizumab Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Fudan University1

Indications

  • Renal Clear Cell Carcinoma1
  • Kidney Cancer1
  • Renal Cell Carcinoma1
  • Cancer1

Other1 trial

Proteomic Guided First-line Precision Treatment of Renal Clear Cell Carcinoma
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.